138 related articles for article (PubMed ID: 12481423)
1. A novel mechanism by which N-(4-hydroxyphenyl)retinamide inhibits breast cancer cell growth: the production of nitric oxide.
Simeone AM; Ekmekcioglu S; Broemeling LD; Grimm EA; Tari AM
Mol Cancer Ther; 2002 Oct; 1(12):1009-17. PubMed ID: 12481423
[TBL] [Abstract][Full Text] [Related]
2. HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide production.
Simeone AM; Broemeling LD; Rosenblum J; Tari AM
Oncogene; 2003 Oct; 22(43):6739-47. PubMed ID: 14555987
[TBL] [Abstract][Full Text] [Related]
3. N-(4-Hydroxyphenyl)retinamide is more potent than other phenylretinamides in inhibiting the growth of BRCA1-mutated breast cancer cells.
Simeone AM; Deng CX; Kelloff GJ; Steele VE; Johnson MM; Tari AM
Carcinogenesis; 2005 May; 26(5):1000-7. PubMed ID: 15695235
[TBL] [Abstract][Full Text] [Related]
4. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
Simeone AM; Colella S; Krahe R; Johnson MM; Mora E; Tari AM
Carcinogenesis; 2006 Mar; 27(3):568-77. PubMed ID: 16199439
[TBL] [Abstract][Full Text] [Related]
5. Experimental studies on the effects of the combined use of N-(4-hydroxyphenyl)retinamide (4-HPR) and tamoxifen (TAM) for estrogen receptor (ER)-negative breast cancer.
Aoyama Y
Kurume Med J; 2002; 49(1-2):27-33. PubMed ID: 12235869
[TBL] [Abstract][Full Text] [Related]
6. Cyclosporin A enhances the apoptotic effects of N-(4-hydroxyphenyl)retinamide in breast cancer cells.
Lim SJ; Simeone AM; Kim CK; Tari AM
Int J Cancer; 2002 Sep; 101(3):243-7. PubMed ID: 12209974
[TBL] [Abstract][Full Text] [Related]
7. Is growth inhibition and induction of apoptosis in lung cancer cell lines by fenretinide [N-(4-hydroxyphenyl)retinamide] sufficient for cancer therapy?
Ohlmann CH; Jung C; Jaques G
Int J Cancer; 2002 Aug; 100(5):520-6. PubMed ID: 12124800
[TBL] [Abstract][Full Text] [Related]
8. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism.
Maurer BJ; Melton L; Billups C; Cabot MC; Reynolds CP
J Natl Cancer Inst; 2000 Dec; 92(23):1897-909. PubMed ID: 11106681
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 is essential for HER2/neu to suppress N- (4-hydroxyphenyl)retinamide apoptotic effects in breast cancer cells.
Simeone AM; Li YJ; Broemeling LD; Johnson MM; Tuna M; Tari AM
Cancer Res; 2004 Feb; 64(4):1224-8. PubMed ID: 14973114
[TBL] [Abstract][Full Text] [Related]
10. 4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.
Villani MG; Appierto V; Cavadini E; Bettiga A; Prinetti A; Clagett-Dame M; Curley RW; Formelli F
Cancer Res; 2006 Mar; 66(6):3238-47. PubMed ID: 16540676
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the insulin-like growth factor-I system by N-(4-hydroxyphenyl)-retinamide in human breast cancer cell lines.
Favoni RE; de Cupis A; Bruno S; Yee D; Ferrera A; Pirani P; Costa A; Decensi A
Br J Cancer; 1998 Jun; 77(12):2138-47. PubMed ID: 9649125
[TBL] [Abstract][Full Text] [Related]
12. 4-HPR Is an Endoplasmic Reticulum Stress Aggravator and Sensitizes Breast Cancer Cells Resistant to TRAIL/Apo2L.
Anding AL; Jones JD; Newton MA; Curley RW; Clagett-Dame M
Anticancer Res; 2018 Aug; 38(8):4403-4416. PubMed ID: 30061204
[TBL] [Abstract][Full Text] [Related]
13. Mechanistic studies of the effects of the retinoid N-(4-hydroxyphenyl)retinamide on prostate cancer cell growth and apoptosis.
Shen JC; Wang TT; Chang S; Hursting SD
Mol Carcinog; 1999 Mar; 24(3):160-8. PubMed ID: 10204800
[TBL] [Abstract][Full Text] [Related]
14. Effect of N-(4-hydroxyphenyl)retinamide on apoptosis in human breast cancer cells.
Wang TT; Phang JM
Cancer Lett; 1996 Oct; 107(1):65-71. PubMed ID: 8913268
[TBL] [Abstract][Full Text] [Related]
15. Fenretinide: induction of apoptosis and endogenous transforming growth factor beta in PC-3 prostate cancer cells.
Roberson KM; Penland SN; Padilla GM; Selvan RS; Kim CS; Fine RL; Robertson CN
Cell Growth Differ; 1997 Jan; 8(1):101-11. PubMed ID: 8993839
[TBL] [Abstract][Full Text] [Related]
16. Combined effect of tamoxifen or interferon-beta and 4-hydroxyphenylretinamide on the growth of breast cancer cell lines.
Coradini D; Biffi A; Pellizzaro C; Pirronello E; Di Fronzo G
Tumour Biol; 1997; 18(1):22-9. PubMed ID: 8989922
[TBL] [Abstract][Full Text] [Related]
17. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL
Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096
[TBL] [Abstract][Full Text] [Related]
18. Inducible nitric oxide synthase is expressed in normal human melanocytes but not in melanoma cells in response to tumor necrosis factor-alpha, interferon-gamma, and lipopolysaccharide.
Fecker LF; Eberle J; Orfanos CE; Geilen CC
J Invest Dermatol; 2002 Jun; 118(6):1019-25. PubMed ID: 12060397
[TBL] [Abstract][Full Text] [Related]
19. Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines.
Maurer BJ; Metelitsa LS; Seeger RC; Cabot MC; Reynolds CP
J Natl Cancer Inst; 1999 Jul; 91(13):1138-46. PubMed ID: 10393722
[TBL] [Abstract][Full Text] [Related]
20. Comparison of N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid in the regulation of retinoid receptor-mediated gene expression in human breast cancer cell lines.
Kazmi SM; Plante RK; Visconti V; Lau CY
Cancer Res; 1996 Mar; 56(5):1056-62. PubMed ID: 8640761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
